Mednet Logo

If a patient had a grade 2 infusion reaction to initial dose of IV Rituximab, can you give subcutaneous Rituximab for cycle 2 or continue with IV Rituximab?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Riverside Methodist Hospitals/OhioHealth
Answered on

I would likely continue IV rituximab until no more infusion reactions are observed before switching to SQ.

Join for free or sign in to see the full answer